Provident Investment Management, Inc. Pfizer Inc Transaction History

Provident Investment Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $9,406 - $12,218	360 Added 2.88%	12,865 $370,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $1,444 - $1,687	45 Added 0.36%	12,505 $414,000
Q2 2023 Aug 09, 2023	BUY	$36.12 - $41.79 $92,286 - $106,773	2,555 Added 25.8%	12,460 $457,000
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $214,281 - $278,963	5,440 Added 121.84%	9,905 $404,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $186,413 - $243,342	4,465 New	4,465 $228,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Provident Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Provident Investment Management, Inc. with notifications on news.